[go: up one dir, main page]

NO149660C - Analogifremgangsmaate for fremstilling av terapeutisk aktiv (r,r) optisk isomer av labetalol - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktiv (r,r) optisk isomer av labetalol

Info

Publication number
NO149660C
NO149660C NO792993A NO792993A NO149660C NO 149660 C NO149660 C NO 149660C NO 792993 A NO792993 A NO 792993A NO 792993 A NO792993 A NO 792993A NO 149660 C NO149660 C NO 149660C
Authority
NO
Norway
Prior art keywords
labetalol
optical
acid addition
isoms
preparation
Prior art date
Application number
NO792993A
Other languages
English (en)
Other versions
NO792993L (no
NO149660B (no
Inventor
Elijah Herman Gold
Chang Wei
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO792993L publication Critical patent/NO792993L/no
Publication of NO149660B publication Critical patent/NO149660B/no
Publication of NO149660C publication Critical patent/NO149660C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO792993A 1978-09-20 1979-09-17 Analogifremgangsmaate for fremstilling av terapeutisk aktiv (r,r) optisk isomer av labetalol NO149660C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94451678A 1978-09-20 1978-09-20

Publications (3)

Publication Number Publication Date
NO792993L NO792993L (no) 1980-03-21
NO149660B NO149660B (no) 1984-02-20
NO149660C true NO149660C (no) 1984-05-30

Family

ID=25481553

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792993A NO149660C (no) 1978-09-20 1979-09-17 Analogifremgangsmaate for fremstilling av terapeutisk aktiv (r,r) optisk isomer av labetalol

Country Status (27)

Country Link
EP (1) EP0009702B1 (no)
JP (3) JPS5555147A (no)
KR (2) KR830000904A (no)
AT (1) ATE351T1 (no)
AU (1) AU528626B2 (no)
CA (1) CA1151211A (no)
CY (1) CY1175A (no)
DD (1) DD150457A5 (no)
DE (1) DE2961263D1 (no)
DK (1) DK387579A (no)
FI (1) FI792884A (no)
GR (1) GR73179B (no)
HK (1) HK13383A (no)
HU (1) HU185523B (no)
IE (1) IE49301B1 (no)
IL (1) IL58258A (no)
KE (1) KE3283A (no)
MY (1) MY8500042A (no)
NO (1) NO149660C (no)
NZ (1) NZ191589A (no)
OA (1) OA06339A (no)
PH (1) PH16794A (no)
PL (1) PL129114B1 (no)
PT (1) PT70191A (no)
SG (1) SG283G (no)
YU (1) YU227379A (no)
ZA (1) ZA794872B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide
IT1194406B (it) * 1983-09-27 1988-09-22 Scharper S P A Procedimento per la preparazione di 2-idrossi-5-01-idrossi-2-((4-fenil-2-butil)ammino) etil benzammide
HU190867B (en) * 1984-01-20 1986-11-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing 2-hydroxy-5-/1-hydroxy-2-/1-methyl-3-phenyl-propyl/-amino/ethyl/-benzamide and pharmaceutically acceptable salts thereof
US4788183A (en) * 1987-11-30 1988-11-29 Schering Corporation Method for treatment of dyslipidemia in humans
US4879233A (en) * 1989-02-10 1989-11-07 Schering Corporation Novel Aspergillus niveus microorganism used for the chiral reduction of carbonyl groups
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
JP2728564B2 (ja) * 1991-08-23 1998-03-18 エヌピーエス・ファーマシウティカルズ・インコーポレイテッド カルシウム受容体活性化分子
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ATE359259T1 (de) 1994-10-21 2007-05-15 Nps Pharma Inc Kalzium-rezeptor aktive verbindungen
ES2326004T3 (es) 1996-05-01 2009-09-28 Nps Pharmaceuticals, Inc. Compuestos activos de receptor de ion inorganico.
IT1313583B1 (it) 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
PL1961735T3 (pl) * 2007-02-22 2010-04-30 Indena Spa Sposób wytwarzania octanu metylowego estru (2r,3s)-3-fenyloizoseryny
JP6245983B2 (ja) * 2010-08-11 2017-12-13 ドレクセル ユニバーシティ パーキンソン病におけるジスキネジアを治療するための新規ｄ３ドーパミン受容体アゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1266058A (no) * 1969-07-08 1972-03-08
GB1541933A (en) * 1975-04-17 1979-03-14 Scherico Ltd Pharmaceutical compositions containing a diastereoisomer of a phenylalkylaminoethanol derivative

Also Published As

Publication number Publication date
KR890001998B1 (ko) 1989-06-07
KR840005307A (ko) 1984-11-05
AU528626B2 (en) 1983-05-05
PL218408A1 (no) 1980-09-08
JPH02167253A (ja) 1990-06-27
PH16794A (en) 1984-02-28
AU5088179A (en) 1980-03-27
HK13383A (en) 1983-04-29
EP0009702A1 (en) 1980-04-16
KR830000904A (ko) 1983-04-28
IE49301B1 (en) 1985-09-18
OA06339A (fr) 1981-06-30
YU227379A (en) 1983-06-30
CA1151211A (en) 1983-08-02
GR73179B (no) 1984-02-14
EP0009702B1 (en) 1981-11-04
ZA794872B (en) 1980-11-26
IE791770L (en) 1980-03-20
PL129114B1 (en) 1984-03-31
IL58258A0 (en) 1979-12-30
NO792993L (no) 1980-03-21
NZ191589A (en) 1984-03-30
HU185523B (en) 1985-02-28
CY1175A (en) 1983-06-10
FI792884A (fi) 1980-03-21
JPS59108749A (ja) 1984-06-23
JPH0210128B2 (no) 1990-03-06
ATE351T1 (de) 1981-11-15
DD150457A5 (de) 1981-09-02
KE3283A (en) 1983-05-13
DE2961263D1 (en) 1982-01-14
SG283G (en) 1983-09-16
IL58258A (en) 1984-01-31
JPS5555147A (en) 1980-04-22
MY8500042A (en) 1985-12-31
NO149660B (no) 1984-02-20
DK387579A (da) 1980-03-21
PT70191A (en) 1979-10-01

Similar Documents

Publication Publication Date Title
NO149660C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv (r,r) optisk isomer av labetalol
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
BR9607001A (pt) Tratamento de incontinéncia urinária com (s)-oxibutinina e (s)-desetiloxibutinina
PT90022A (pt) Processo para a preparacao de derivados cefem e dos intermediarios correspondentes
FI911131A0 (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
MY111055A (en) Pharmaceutical composition and process for the preparation thereof
DK562488A (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
NO164021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktiv (r,s)-5-amino-hepta-5,6-diensyre, (s)-4-aminohepta-5,6-diensyre og farmasoeytisk akseptable salter derav.
EE9800141A (et) Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
WO1990003172A3 (en) Bile acids for treatment of viral infections
ES524375A0 (es) Un procedimiento para preparar un compuesto de nitrato piridilalquilico
SE8001981L (sv) Kompositioner for behandling av glaukom
ES8403135A1 (es) Un procedimiento para la preparacion de acido 6,-metoxi-6, -2-2-metilfenoxicarbonil-2-(tien-3-il) acetamido penicilanico.
GB2316406A (en) Free radical scavenger molecules